RESTON, Va.--The effectiveness of chemotherapy in patients with advanced breast cancer can be evaluated earlier by using ¹⁸F-FDG positron emission tomography (PET) imaging over other conventional imaging procedures, according to an article in the July issue of the Society of Nuclear Medicine's Journal of Nuclear Medicine.

PET imaging performed at baseline and after the initiation of treatment "allowed prediction of response as early as after the first cycle of chemotherapy," said Norbert Avril, M.D., chief of the division of nuclear medicine at the University of Pittsburgh Medical Center, Pittsburgh, Pa. Conventional imaging procedures, such as computed tomography (CT), magnetic resonance imaging (MRI), plain film radiography and ultrasound, do not reliably predict therapy response early in the course of treatment, explained the co-author of "Early Prediction of Response to Chemotherapy in Metastatic Breast Cancer Using Sequential ¹⁸F-FDG PET."

Metastatic breast cancer is the most advanced stage of breast cancer. Cancer cells have spread past the breast and underarm lymph nodes to other areas of the body, continuing to grow, multiply and possibly spread to other regions of the body. Chemotherapy, which uses drugs to stop the growth of cancer cells, either by killing the cells or stopping the cells from dividing, is typically used with patients. At this advanced stage of the disease, the aim of treatment is to improve survival and quality of life, since the disease is generally not curable, said Avril. It's essential to identify those individuals who don't respond to chemotherapy early "to avoid ineffective therapies and unnecessary side effects," he noted. This ability to individualize treatment gives patients and physicians options not previously available, added Avril, indicating that additional studies are needed to determine how to use ¹⁸F-FDG PET in a clinical setting.

PET is a powerful medical imaging
'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-708-9000
Society of Nuclear Medicine
26-Jul-2005

Page: 1 2
Related biology news :

1. Research aims to identify markers for menopausal women at risk for deadly blood clot
2. Progesterone therapy and preterm birth: More evidence helps identify women who can benefit
3. After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis
4. U-M researchers identify gene involved in breast cancer
5. Scientists identify 2 distinct Parkinsons networks
6. NIEHS researchers identify enzyme critical in DNA replication
7. Researchers identify genetic mutation that may alter tumor cell proliferation
8. Researchers discover method for identifying how cancer evades the immune system
9. Scientists identify first gene linked to scoliosis
10. LIAI researchers identify a potential role for retinoic acid in autoimmune and inflammatory diseases
11. Researchers identify fifth gene responsible for Joubert syndrome